November 18, 2014 by Enis • Commentary

Nassim Taleb has been making headlines lately in his relentless attack on Genetically Modified Organisms and the corresponding lobbyists and industry promoters.  Mark Buchanan summed up the research in a recent Bloomberg article: Like many …

Continue reading
November 18, 2014 by Enis • Commentary

Event:  TGT reports its fiscal Q3 earnings tomorrow morning before the open.  The options market is implying about a 3.5% one day move, which is slightly above the 4 quarter average of 3.25% and the 8 …

Continue reading
November 17, 2014 by Enis • Commentary

Event:  HD reports its fiscal Q3 earnings tomorrow morning before the open.  The options market is implying about a 3.25% one day move, which is in line with both the 4 and 8 quarter average of …

Continue reading
November 14, 2014 by Enis • Commentary

I bought a call position in NLY on Oct. 1st with a twofold thesis: 1)  NLY was trading near its all-time low Price / Book ratio, indicating a good fundamental value, particularly since long-term rates …

Continue reading